

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.54267185 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.97920265 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.10534819 |
| 4 | myofibril assembly (GO:0030239) | 7.82874675 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.51860121 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.34067068 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.03331437 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.70944594 |
| 9 | cardiac muscle cell development (GO:0055013) | 6.59716182 |
| 10 | * cardiac muscle contraction (GO:0060048) | 6.59582117 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.49845467 |
| 12 | muscle filament sliding (GO:0030049) | 6.45098375 |
| 13 | actin-myosin filament sliding (GO:0033275) | 6.45098375 |
| 14 | plasma membrane repair (GO:0001778) | 6.34116694 |
| 15 | tricarboxylic acid cycle (GO:0006099) | 6.34087083 |
| 16 | cardiac cell development (GO:0055006) | 6.19700960 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 5.99807378 |
| 18 | adult heart development (GO:0007512) | 5.92443095 |
| 19 | actomyosin structure organization (GO:0031032) | 5.90737032 |
| 20 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.79758761 |
| 21 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.79481990 |
| 22 | cardiac muscle hypertrophy (GO:0003300) | 5.60304552 |
| 23 | regulation of sarcomere organization (GO:0060297) | 5.40596825 |
| 24 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.37565788 |
| 25 | actin-mediated cell contraction (GO:0070252) | 5.35499536 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 5.34226743 |
| 27 | heart trabecula formation (GO:0060347) | 5.34204429 |
| 28 | * ventricular cardiac muscle cell action potential (GO:0086005) | 5.31829647 |
| 29 | striated muscle hypertrophy (GO:0014897) | 5.29429801 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.23453282 |
| 31 | * regulation of actin filament-based movement (GO:1903115) | 5.22151984 |
| 32 | muscle tissue morphogenesis (GO:0060415) | 5.21338662 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.18799076 |
| 34 | carnitine shuttle (GO:0006853) | 5.12478448 |
| 35 | regulation of the force of heart contraction (GO:0002026) | 5.04751099 |
| 36 | cardiac chamber formation (GO:0003207) | 5.03195649 |
| 37 | * striated muscle contraction (GO:0006941) | 5.02946379 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 4.98540112 |
| 39 | * regulation of striated muscle contraction (GO:0006942) | 4.82485341 |
| 40 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.79964088 |
| 41 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.73003759 |
| 42 | heart contraction (GO:0060047) | 4.70603018 |
| 43 | heart process (GO:0003015) | 4.70603018 |
| 44 | muscle hypertrophy (GO:0014896) | 4.67868055 |
| 45 | cardiac ventricle formation (GO:0003211) | 4.66015031 |
| 46 | cell communication by electrical coupling (GO:0010644) | 4.65201397 |
| 47 | * cell communication involved in cardiac conduction (GO:0086065) | 4.53557715 |
| 48 | fatty acid transmembrane transport (GO:1902001) | 4.42654548 |
| 49 | * regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.37680450 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 4.30950728 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 4.30950728 |
| 52 | relaxation of cardiac muscle (GO:0055119) | 4.26571288 |
| 53 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.25134251 |
| 54 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.22224845 |
| 55 | negative regulation of potassium ion transport (GO:0043267) | 4.18421367 |
| 56 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.18240113 |
| 57 | atrial septum morphogenesis (GO:0060413) | 4.14739713 |
| 58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.14621806 |
| 59 | * regulation of membrane repolarization (GO:0060306) | 4.10359565 |
| 60 | * regulation of cardiac muscle contraction (GO:0055117) | 4.10182502 |
| 61 | actin filament-based movement (GO:0030048) | 4.06863845 |
| 62 | adrenergic receptor signaling pathway (GO:0071875) | 4.05929426 |
| 63 | * regulation of heart rate (GO:0002027) | 4.05884108 |
| 64 | oxygen transport (GO:0015671) | 4.04292608 |
| 65 | cellular response to epinephrine stimulus (GO:0071872) | 4.03576752 |
| 66 | regulation of cardioblast differentiation (GO:0051890) | 3.99897789 |
| 67 | * bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.98131315 |
| 68 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.95174211 |
| 69 | regulation of ATPase activity (GO:0043462) | 3.90284511 |
| 70 | regulation of ATP catabolic process (GO:1903289) | 3.90284511 |
| 71 | atrioventricular valve morphogenesis (GO:0003181) | 3.89920380 |
| 72 | response to epinephrine (GO:0071871) | 3.89611733 |
| 73 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.88809527 |
| 74 | muscle hypertrophy in response to stress (GO:0003299) | 3.88809527 |
| 75 | cardiac muscle adaptation (GO:0014887) | 3.88809527 |
| 76 | NADH metabolic process (GO:0006734) | 3.87840230 |
| 77 | 2-oxoglutarate metabolic process (GO:0006103) | 3.86970965 |
| 78 | * regulation of heart contraction (GO:0008016) | 3.86188123 |
| 79 | negative regulation of protein localization to cell surface (GO:2000009) | 3.85224657 |
| 80 | ATP synthesis coupled proton transport (GO:0015986) | 3.83377932 |
| 81 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.83377932 |
| 82 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.81960515 |
| 83 | response to caffeine (GO:0031000) | 3.78594650 |
| 84 | carnitine transmembrane transport (GO:1902603) | 3.77245488 |
| 85 | positive regulation of cation channel activity (GO:2001259) | 3.72453548 |
| 86 | ventricular cardiac muscle cell development (GO:0055015) | 3.71854044 |
| 87 | creatine metabolic process (GO:0006600) | 3.71621046 |
| 88 | respiratory electron transport chain (GO:0022904) | 3.71248672 |
| 89 | * cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.69901188 |
| 90 | positive regulation of heart rate (GO:0010460) | 3.69239698 |
| 91 | * cardiac muscle cell action potential (GO:0086001) | 3.68917988 |
| 92 | striated muscle cell development (GO:0055002) | 3.68463708 |
| 93 | positive regulation of heart contraction (GO:0045823) | 3.66973228 |
| 94 | * regulation of cardiac muscle cell contraction (GO:0086004) | 3.66559894 |
| 95 | electron transport chain (GO:0022900) | 3.59926858 |
| 96 | * regulation of muscle contraction (GO:0006937) | 3.58970946 |
| 97 | oxidative phosphorylation (GO:0006119) | 3.58961927 |
| 98 | regulation of sequestering of triglyceride (GO:0010889) | 3.56692128 |
| 99 | detection of calcium ion (GO:0005513) | 3.55848828 |
| 100 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.54943783 |
| 101 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.53760715 |
| 102 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.53760715 |
| 103 | regulation of sulfur metabolic process (GO:0042762) | 3.50780213 |
| 104 | muscle cell fate commitment (GO:0042693) | 3.48792674 |
| 105 | * muscle system process (GO:0003012) | 3.48219113 |
| 106 | cell migration involved in heart development (GO:0060973) | 3.48113836 |
| 107 | amino-acid betaine transport (GO:0015838) | 3.42495181 |
| 108 | carnitine transport (GO:0015879) | 3.42495181 |
| 109 | positive regulation of ATP catabolic process (GO:1903291) | 3.42256224 |
| 110 | positive regulation of ATPase activity (GO:0032781) | 3.42256224 |
| 111 | cardiac muscle tissue development (GO:0048738) | 3.40511235 |
| 112 | potassium ion export (GO:0071435) | 3.39218126 |
| 113 | trabecula formation (GO:0060343) | 3.38769422 |
| 114 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.38736112 |
| 115 | * regulation of muscle system process (GO:0090257) | 3.35091917 |
| 116 | * muscle contraction (GO:0006936) | 3.32091218 |
| 117 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.30227083 |
| 118 | regulation of fatty acid oxidation (GO:0046320) | 3.27085803 |
| 119 | muscle cell development (GO:0055001) | 3.26392465 |
| 120 | aspartate family amino acid catabolic process (GO:0009068) | 3.25126033 |
| 121 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.23660376 |
| 122 | striated muscle adaptation (GO:0014888) | 3.20476569 |
| 123 | regulation of cardioblast proliferation (GO:0003264) | 3.17328338 |
| 124 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.17328338 |
| 125 | gap junction assembly (GO:0016264) | 3.16505398 |
| 126 | muscle adaptation (GO:0043500) | 3.11440786 |
| 127 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.02984110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.03290714 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.95839638 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.05187164 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.01485567 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.01485567 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.64239551 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.44667340 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.36349023 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.04575434 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.02236227 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.91306959 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.64597248 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.41988901 |
| 14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.21612834 |
| 15 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.16726505 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10948564 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.94429135 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.91765962 |
| 19 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.90359965 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81808369 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78287194 |
| 22 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.75607856 |
| 23 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.72669419 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66362209 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.59491729 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58117882 |
| 27 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.57359136 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.56010809 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54992058 |
| 30 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.48315199 |
| 31 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.46834007 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42487503 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41823915 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40620155 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39948905 |
| 36 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35628880 |
| 37 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33627878 |
| 38 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.33230328 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33016964 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31235432 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30054813 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29595621 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27651333 |
| 44 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22997801 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22994475 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21094305 |
| 47 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.19313590 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18960897 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17305927 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16304585 |
| 51 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.14348019 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13689879 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11576837 |
| 54 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11447246 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10963329 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10901695 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10778486 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09215663 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08323906 |
| 60 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07534318 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07038629 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06009953 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05589302 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05497853 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04638825 |
| 66 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04411323 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02088710 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02024701 |
| 69 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.01695858 |
| 70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01652267 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00747310 |
| 72 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99736452 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99681529 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99680033 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99531003 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99429778 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98587596 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98533465 |
| 79 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97896076 |
| 80 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97464124 |
| 81 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97280159 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97242347 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94841918 |
| 84 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94818342 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94589879 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94202970 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 0.92817802 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92210097 |
| 89 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90922990 |
| 90 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90403925 |
| 91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89926532 |
| 92 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88938060 |
| 93 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.88494091 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87442462 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87385796 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86968482 |
| 97 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86958474 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86749425 |
| 99 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86563709 |
| 100 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.85649764 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85593287 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85515942 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85259991 |
| 104 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.84145673 |
| 105 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83854078 |
| 106 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83632776 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83390607 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83087079 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82991329 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82279616 |
| 111 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81976493 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81914380 |
| 113 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.81659950 |
| 114 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.81473550 |
| 115 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.81473550 |
| 116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81413235 |
| 117 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80609686 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80313344 |
| 119 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80027687 |
| 120 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.79547738 |
| 121 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.79045850 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78825938 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78667833 |
| 124 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78302347 |
| 125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77921965 |
| 126 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.77474718 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77375096 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76853199 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.76376801 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.75988833 |
| 131 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.74759622 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.74428726 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73193493 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73193493 |
| 135 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.73077687 |
| 136 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.72942596 |
| 137 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.72306894 |
| 138 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.70973922 |
| 139 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.70866195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.39749462 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.02354048 |
| 3 | MP0003646_muscle_fatigue | 5.56223277 |
| 4 | MP0000751_myopathy | 5.24774017 |
| 5 | * MP0004215_abnormal_myocardial_fiber | 4.79961286 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.23550052 |
| 7 | MP0005330_cardiomyopathy | 4.02692126 |
| 8 | MP0000749_muscle_degeneration | 3.64897878 |
| 9 | * MP0002972_abnormal_cardiac_muscle | 3.13935306 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.04430843 |
| 11 | * MP0004087_abnormal_muscle_fiber | 3.01094714 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.85036754 |
| 13 | * MP0003137_abnormal_impulse_conducting | 2.82039275 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.63735423 |
| 15 | * MP0010630_abnormal_cardiac_muscle | 2.61500028 |
| 16 | * MP0005385_cardiovascular_system_phenoty | 2.61070963 |
| 17 | * MP0001544_abnormal_cardiovascular_syste | 2.61070963 |
| 18 | MP0006138_congestive_heart_failure | 2.54737299 |
| 19 | MP0004484_altered_response_of | 2.51961177 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.42832119 |
| 21 | MP0004130_abnormal_muscle_cell | 2.38525383 |
| 22 | MP0003828_pulmonary_edema | 2.31761419 |
| 23 | MP0002269_muscular_atrophy | 2.20719572 |
| 24 | * MP0004085_abnormal_heartbeat | 2.14614722 |
| 25 | MP0004510_myositis | 2.14370446 |
| 26 | MP0005369_muscle_phenotype | 1.97089924 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.94466786 |
| 28 | MP0000759_abnormal_skeletal_muscle | 1.86888702 |
| 29 | MP0000747_muscle_weakness | 1.85393945 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.81935369 |
| 31 | MP0002127_abnormal_cardiovascular_syste | 1.70421927 |
| 32 | MP0004233_abnormal_muscle_weight | 1.62919866 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.54085151 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.52815664 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.40377516 |
| 36 | MP0005670_abnormal_white_adipose | 1.34030574 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.29375863 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.26096528 |
| 39 | MP0003279_aneurysm | 1.22900159 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.21041823 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.19675758 |
| 42 | MP0000343_altered_response_to | 1.16375445 |
| 43 | * MP0000266_abnormal_heart_morphology | 1.14859578 |
| 44 | MP0005165_increased_susceptibility_to | 1.14333039 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.01213823 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.99772629 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 0.91024999 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 0.89354070 |
| 49 | MP0001661_extended_life_span | 0.88515605 |
| 50 | MP0002108_abnormal_muscle_morphology | 0.87339436 |
| 51 | MP0002128_abnormal_blood_circulation | 0.85281044 |
| 52 | MP0003566_abnormal_cell_adhesion | 0.81179057 |
| 53 | MP0000230_abnormal_systemic_arterial | 0.80321057 |
| 54 | MP0002909_abnormal_adrenal_gland | 0.78691965 |
| 55 | MP0001299_abnormal_eye_distance/ | 0.76652959 |
| 56 | MP0005266_abnormal_metabolism | 0.75583123 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.74603009 |
| 58 | MP0005503_abnormal_tendon_morphology | 0.71805132 |
| 59 | MP0003941_abnormal_skin_development | 0.70536295 |
| 60 | MP0000767_abnormal_smooth_muscle | 0.68754205 |
| 61 | MP0008004_abnormal_stomach_pH | 0.67856028 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.67723078 |
| 63 | MP0000733_abnormal_muscle_development | 0.67306137 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.66109827 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 0.64452532 |
| 66 | MP0010030_abnormal_orbit_morphology | 0.59161028 |
| 67 | MP0005187_abnormal_penis_morphology | 0.59035056 |
| 68 | MP0003091_abnormal_cell_migration | 0.56346741 |
| 69 | MP0004272_abnormal_basement_membrane | 0.55567280 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 0.52628791 |
| 71 | MP0004043_abnormal_pH_regulation | 0.50498868 |
| 72 | MP0005409_darkened_coat_color | 0.48954226 |
| 73 | MP0002925_abnormal_cardiovascular_devel | 0.48537137 |
| 74 | MP0002971_abnormal_brown_adipose | 0.47632305 |
| 75 | MP0005451_abnormal_body_composition | 0.46711440 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.44120127 |
| 77 | MP0000762_abnormal_tongue_morphology | 0.43989956 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.43841517 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.43285281 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.42004521 |
| 81 | MP0003984_embryonic_growth_retardation | 0.40925527 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 0.39918534 |
| 83 | MP0002088_abnormal_embryonic_growth/wei | 0.39537283 |
| 84 | MP0004147_increased_porphyrin_level | 0.38675011 |
| 85 | MP0004270_analgesia | 0.38125162 |
| 86 | MP0001784_abnormal_fluid_regulation | 0.37508216 |
| 87 | MP0001614_abnormal_blood_vessel | 0.37275665 |
| 88 | MP0005275_abnormal_skin_tensile | 0.36980724 |
| 89 | MP0002254_reproductive_system_inflammat | 0.35851291 |
| 90 | MP0002822_catalepsy | 0.35485461 |
| 91 | MP0005386_behavior/neurological_phenoty | 0.35042294 |
| 92 | MP0004924_abnormal_behavior | 0.35042294 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.33482020 |
| 94 | MP0003948_abnormal_gas_homeostasis | 0.32838279 |
| 95 | MP0005535_abnormal_body_temperature | 0.31281727 |
| 96 | MP0003045_fibrosis | 0.30741878 |
| 97 | MP0002090_abnormal_vision | 0.30561363 |
| 98 | MP0001542_abnormal_bone_strength | 0.29651403 |
| 99 | MP0001958_emphysema | 0.28948187 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.27417297 |
| 101 | MP0001730_embryonic_growth_arrest | 0.26916398 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.26877844 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.26166570 |
| 104 | MP0001915_intracranial_hemorrhage | 0.24028693 |
| 105 | MP0009840_abnormal_foam_cell | 0.23514522 |
| 106 | MP0002295_abnormal_pulmonary_circulatio | 0.23191224 |
| 107 | MP0001984_abnormal_olfaction | 0.22982774 |
| 108 | MP0005334_abnormal_fat_pad | 0.22508128 |
| 109 | MP0009115_abnormal_fat_cell | 0.21596356 |
| 110 | MP0002133_abnormal_respiratory_system | 0.21104709 |
| 111 | MP0005388_respiratory_system_phenotype | 0.21104709 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.20886898 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.20357102 |
| 114 | MP0000249_abnormal_blood_vessel | 0.20351886 |
| 115 | MP0008874_decreased_physiological_sensi | 0.20302448 |
| 116 | MP0005380_embryogenesis_phenotype | 0.20143512 |
| 117 | MP0001672_abnormal_embryogenesis/_devel | 0.20143512 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.20062574 |
| 119 | MP0003935_abnormal_craniofacial_develop | 0.18208451 |
| 120 | MP0005023_abnormal_wound_healing | 0.18074259 |
| 121 | MP0000579_abnormal_nail_morphology | 0.17881389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Sudden death (HP:0001699) | 8.26344496 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.56515241 |
| 3 | * Atrial fibrillation (HP:0005110) | 6.46731698 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.45936375 |
| 5 | Muscle fiber splitting (HP:0003555) | 6.05890848 |
| 6 | * Primary atrial arrhythmia (HP:0001692) | 6.04760217 |
| 7 | * Supraventricular tachycardia (HP:0004755) | 5.83802380 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.75251358 |
| 9 | * Supraventricular arrhythmia (HP:0005115) | 5.72592300 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 5.72151430 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 5.61686557 |
| 12 | * Lipoatrophy (HP:0100578) | 5.54643941 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 5.33171320 |
| 14 | Exercise-induced myalgia (HP:0003738) | 5.29885143 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 5.27495533 |
| 16 | Subaortic stenosis (HP:0001682) | 5.18375731 |
| 17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.18375731 |
| 18 | * Syncope (HP:0001279) | 4.94862494 |
| 19 | * Dilated cardiomyopathy (HP:0001644) | 4.58475529 |
| 20 | Myoglobinuria (HP:0002913) | 4.54328301 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.29803553 |
| 22 | * Prolonged QT interval (HP:0001657) | 4.10036740 |
| 23 | Increased connective tissue (HP:0009025) | 4.06953590 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 4.06605009 |
| 25 | * Ventricular arrhythmia (HP:0004308) | 4.05558633 |
| 26 | * Palpitations (HP:0001962) | 3.98340684 |
| 27 | Difficulty running (HP:0009046) | 3.59713827 |
| 28 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.44588934 |
| 29 | * Bundle branch block (HP:0011710) | 3.41125069 |
| 30 | Myotonia (HP:0002486) | 3.40672474 |
| 31 | * Heart block (HP:0012722) | 3.39723228 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.37472174 |
| 33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.29574060 |
| 34 | * Abnormal atrioventricular conduction (HP:0005150) | 3.21433558 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.21371038 |
| 36 | Hypoplastic heart (HP:0001961) | 3.10470777 |
| 37 | Aplasia of the musculature (HP:0100854) | 3.05141363 |
| 38 | * Abnormal EKG (HP:0003115) | 3.03585180 |
| 39 | Nemaline bodies (HP:0003798) | 3.03195036 |
| 40 | * Atrioventricular block (HP:0001678) | 2.98721128 |
| 41 | Muscle fiber inclusion bodies (HP:0100299) | 2.94503353 |
| 42 | Testicular atrophy (HP:0000029) | 2.84511703 |
| 43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.83129171 |
| 44 | Ketoacidosis (HP:0001993) | 2.81911693 |
| 45 | Hepatic necrosis (HP:0002605) | 2.80835428 |
| 46 | * Left ventricular hypertrophy (HP:0001712) | 2.79445023 |
| 47 | Acute necrotizing encephalopathy (HP:0006965) | 2.78365404 |
| 48 | Hypoplastic left heart (HP:0004383) | 2.76162530 |
| 49 | * Palmoplantar keratoderma (HP:0000982) | 2.70733814 |
| 50 | * Ventricular fibrillation (HP:0001663) | 2.69804583 |
| 51 | Popliteal pterygium (HP:0009756) | 2.66515508 |
| 52 | Limb-girdle muscle atrophy (HP:0003797) | 2.63533337 |
| 53 | Rimmed vacuoles (HP:0003805) | 2.62925756 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.62619510 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.57153493 |
| 56 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57103027 |
| 57 | Fatigable weakness (HP:0003473) | 2.51153245 |
| 58 | Abnormality of the neuromuscular junction (HP:0003398) | 2.51153245 |
| 59 | Type 2 muscle fiber atrophy (HP:0003554) | 2.47351402 |
| 60 | Bulbar palsy (HP:0001283) | 2.43116756 |
| 61 | Hepatocellular necrosis (HP:0001404) | 2.42198709 |
| 62 | Areflexia of lower limbs (HP:0002522) | 2.38885916 |
| 63 | Acute encephalopathy (HP:0006846) | 2.38438758 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.35279182 |
| 65 | Ragged-red muscle fibers (HP:0003200) | 2.33499145 |
| 66 | Conjunctival hamartoma (HP:0100780) | 2.31706558 |
| 67 | Progressive macrocephaly (HP:0004481) | 2.31627111 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.31269832 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.29977309 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29977309 |
| 71 | Dysmetric saccades (HP:0000641) | 2.28979467 |
| 72 | Muscle fiber atrophy (HP:0100295) | 2.28877216 |
| 73 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.26991164 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.26675147 |
| 75 | Weak cry (HP:0001612) | 2.26565239 |
| 76 | Cerebral edema (HP:0002181) | 2.25397324 |
| 77 | Abnormality of the foot musculature (HP:0001436) | 2.25340531 |
| 78 | Mitochondrial inheritance (HP:0001427) | 2.23260493 |
| 79 | Neck muscle weakness (HP:0000467) | 2.22112494 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18046435 |
| 81 | * Sudden cardiac death (HP:0001645) | 2.17818649 |
| 82 | Pheochromocytoma (HP:0002666) | 2.16100243 |
| 83 | Hypoplastic ischia (HP:0003175) | 2.15120340 |
| 84 | Gowers sign (HP:0003391) | 2.14424512 |
| 85 | Steppage gait (HP:0003376) | 2.12137335 |
| 86 | Foot dorsiflexor weakness (HP:0009027) | 2.11277380 |
| 87 | Increased CSF lactate (HP:0002490) | 2.09877149 |
| 88 | Muscle stiffness (HP:0003552) | 2.07416949 |
| 89 | Large for gestational age (HP:0001520) | 2.07056278 |
| 90 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.05221917 |
| 91 | Hamartoma of the eye (HP:0010568) | 2.02790906 |
| 92 | * Congestive heart failure (HP:0001635) | 2.01821602 |
| 93 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01518532 |
| 94 | Ketosis (HP:0001946) | 2.01212143 |
| 95 | Type 1 muscle fiber predominance (HP:0003803) | 1.99311814 |
| 96 | Respiratory failure (HP:0002878) | 1.98234450 |
| 97 | EMG: neuropathic changes (HP:0003445) | 1.97838334 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96084461 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95953075 |
| 100 | Lactic acidosis (HP:0003128) | 1.95909701 |
| 101 | Double outlet right ventricle (HP:0001719) | 1.94268682 |
| 102 | Congenital malformation of the right heart (HP:0011723) | 1.94268682 |
| 103 | Muscular dystrophy (HP:0003560) | 1.93555842 |
| 104 | Broad metatarsal (HP:0001783) | 1.93545444 |
| 105 | Easy fatigability (HP:0003388) | 1.93388764 |
| 106 | Generalized muscle weakness (HP:0003324) | 1.92886051 |
| 107 | Exercise intolerance (HP:0003546) | 1.92341332 |
| 108 | Neuroendocrine neoplasm (HP:0100634) | 1.90647724 |
| 109 | Scapular winging (HP:0003691) | 1.88935410 |
| 110 | Neoplasm of the adrenal gland (HP:0100631) | 1.88205693 |
| 111 | Central scotoma (HP:0000603) | 1.87903863 |
| 112 | Abnormality of the ischium (HP:0003174) | 1.86356771 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85237447 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 1.85237447 |
| 115 | Hyperalaninemia (HP:0003348) | 1.85237447 |
| 116 | Lower limb amyotrophy (HP:0007210) | 1.85143389 |
| 117 | Lymphangioma (HP:0100764) | 1.84930945 |
| 118 | Proximal amyotrophy (HP:0007126) | 1.84916864 |
| 119 | Thin ribs (HP:0000883) | 1.84826852 |
| 120 | Neoplasm of head and neck (HP:0012288) | 1.83117796 |
| 121 | Esophageal neoplasm (HP:0100751) | 1.83117796 |
| 122 | Amniotic constriction ring (HP:0009775) | 1.82789679 |
| 123 | Abnormality of placental membranes (HP:0011409) | 1.82789679 |
| 124 | Aneurysm (HP:0002617) | 1.81380397 |
| 125 | Aortic aneurysm (HP:0004942) | 1.79472218 |
| 126 | Skin nodule (HP:0200036) | 1.78967900 |
| 127 | Resting tremor (HP:0002322) | 1.77659788 |
| 128 | Generalized amyotrophy (HP:0003700) | 1.75702039 |
| 129 | Frequent falls (HP:0002359) | 1.73540269 |
| 130 | Progressive muscle weakness (HP:0003323) | 1.72190091 |
| 131 | Fetal akinesia sequence (HP:0001989) | 1.69753572 |
| 132 | Pterygium (HP:0001059) | 1.66568555 |
| 133 | Malignant hyperthermia (HP:0002047) | 1.65724815 |
| 134 | Hip contracture (HP:0003273) | 1.64798330 |
| 135 | Pulmonary artery stenosis (HP:0004415) | 1.62462974 |
| 136 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.58126083 |
| 137 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.56422771 |
| 138 | Increased serum pyruvate (HP:0003542) | 1.53650599 |
| 139 | Round ear (HP:0100830) | 1.53246895 |
| 140 | Preauricular pit (HP:0004467) | 1.50975174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.64707542 |
| 2 | LMTK2 | 4.33837211 |
| 3 | PHKG1 | 3.92787990 |
| 4 | PHKG2 | 3.92787990 |
| 5 | MYLK | 3.92199370 |
| 6 | OBSCN | 3.58630903 |
| 7 | PDK4 | 3.34726815 |
| 8 | PDK3 | 3.34726815 |
| 9 | PKN2 | 3.28778089 |
| 10 | DMPK | 3.27027895 |
| 11 | TRIB3 | 3.02867582 |
| 12 | MUSK | 2.94511325 |
| 13 | BCKDK | 2.28912847 |
| 14 | PIK3CA | 2.20139440 |
| 15 | TIE1 | 2.11205332 |
| 16 | LIMK1 | 2.01371080 |
| 17 | NEK1 | 2.00933558 |
| 18 | PDK2 | 1.95757663 |
| 19 | PINK1 | 1.89165482 |
| 20 | STK24 | 1.84067065 |
| 21 | PAK3 | 1.71299619 |
| 22 | GRK7 | 1.66237843 |
| 23 | PRKD1 | 1.45756316 |
| 24 | MAP3K6 | 1.38449191 |
| 25 | ILK | 1.28068441 |
| 26 | MOS | 1.25044909 |
| 27 | MARK1 | 1.19120006 |
| 28 | ROCK1 | 1.11991776 |
| 29 | WNK4 | 1.10600380 |
| 30 | STK4 | 1.08987263 |
| 31 | CDC42BPA | 1.06685942 |
| 32 | RIPK1 | 1.04247748 |
| 33 | * CAMK2D | 1.03366917 |
| 34 | MAPK12 | 0.97097847 |
| 35 | MAP3K7 | 0.96306264 |
| 36 | INSRR | 0.94942637 |
| 37 | PIK3CG | 0.94741468 |
| 38 | MAPKAPK3 | 0.89788440 |
| 39 | MAP3K5 | 0.89462011 |
| 40 | PDGFRA | 0.88236433 |
| 41 | PRKAA1 | 0.86825595 |
| 42 | CAMK4 | 0.82559354 |
| 43 | TRPM7 | 0.81246326 |
| 44 | PKN1 | 0.81060636 |
| 45 | DAPK3 | 0.81013132 |
| 46 | STK38 | 0.80284079 |
| 47 | STK38L | 0.78948999 |
| 48 | ZAK | 0.77631655 |
| 49 | PRKAA2 | 0.77437567 |
| 50 | FLT3 | 0.77398587 |
| 51 | ROCK2 | 0.75443017 |
| 52 | EPHB1 | 0.75173810 |
| 53 | CAMK2A | 0.71484665 |
| 54 | WNK1 | 0.69213172 |
| 55 | PTK2 | 0.68264880 |
| 56 | RPS6KL1 | 0.66363570 |
| 57 | RPS6KC1 | 0.66363570 |
| 58 | ICK | 0.64192436 |
| 59 | KDR | 0.63266030 |
| 60 | TGFBR2 | 0.61210001 |
| 61 | CAMK2B | 0.59550450 |
| 62 | CAMK1 | 0.56546459 |
| 63 | RPS6KA6 | 0.56375316 |
| 64 | PTK2B | 0.55596310 |
| 65 | PRKCE | 0.54406509 |
| 66 | PRKACB | 0.52674619 |
| 67 | MAP2K3 | 0.50952472 |
| 68 | TESK1 | 0.49066650 |
| 69 | MET | 0.47442261 |
| 70 | MAP3K3 | 0.45264002 |
| 71 | MAPK4 | 0.45018412 |
| 72 | EEF2K | 0.44479245 |
| 73 | PDPK1 | 0.43845333 |
| 74 | PRKACG | 0.43684971 |
| 75 | PAK2 | 0.43467184 |
| 76 | STK39 | 0.42968815 |
| 77 | PRKACA | 0.42241809 |
| 78 | SIK1 | 0.40529145 |
| 79 | AKT2 | 0.40059437 |
| 80 | PTK6 | 0.39467957 |
| 81 | PRKCH | 0.39003358 |
| 82 | PRKD3 | 0.38638118 |
| 83 | CAMK2G | 0.36115093 |
| 84 | PAK4 | 0.35843807 |
| 85 | FER | 0.34742450 |
| 86 | PDK1 | 0.34132001 |
| 87 | RET | 0.33302343 |
| 88 | LATS2 | 0.32192447 |
| 89 | MTOR | 0.31940652 |
| 90 | UHMK1 | 0.30432688 |
| 91 | RPS6KA1 | 0.30358467 |
| 92 | EPHB2 | 0.29784445 |
| 93 | SCYL2 | 0.26506277 |
| 94 | MELK | 0.25091504 |
| 95 | SGK3 | 0.24926906 |
| 96 | MAPK10 | 0.24530752 |
| 97 | PRKG2 | 0.24467659 |
| 98 | JAK1 | 0.24342612 |
| 99 | FGFR4 | 0.23877129 |
| 100 | ERBB4 | 0.23307303 |
| 101 | PAK6 | 0.22761989 |
| 102 | NEK9 | 0.22733245 |
| 103 | LATS1 | 0.22162975 |
| 104 | RPS6KA2 | 0.21844372 |
| 105 | KSR2 | 0.21502974 |
| 106 | EPHA3 | 0.20191185 |
| 107 | ITK | 0.18817813 |
| 108 | RPS6KA3 | 0.18357050 |
| 109 | DDR2 | 0.18185308 |
| 110 | PDGFRB | 0.18028498 |
| 111 | PRKG1 | 0.17823447 |
| 112 | AKT1 | 0.17452786 |
| 113 | MAPK9 | 0.16983176 |
| 114 | SGK1 | 0.16438886 |
| 115 | MAP3K10 | 0.16350277 |
| 116 | LRRK2 | 0.15324893 |
| 117 | AURKB | 0.15313136 |
| 118 | CAMK1D | 0.15257827 |
| 119 | TAOK1 | 0.15029248 |
| 120 | MAPK7 | 0.14867166 |
| 121 | MAP3K4 | 0.14839860 |
| 122 | STK3 | 0.14712219 |
| 123 | NME2 | 0.13860372 |
| 124 | MAP2K1 | 0.13724094 |
| 125 | STK11 | 0.13638276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.74493487 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.33220623 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.23559507 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.01551908 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.81271136 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.50432030 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.10436428 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.98686663 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.86516828 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.82012839 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.61621960 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.31935006 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.20865172 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.15629196 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14334709 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.99668026 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.89167995 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.83483067 |
| 19 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76915776 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66076456 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41122873 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32243732 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20236372 |
| 24 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07406807 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06782153 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.05649484 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04993287 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03333667 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00758480 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97640611 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97222249 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89064645 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 0.87966556 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86834382 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80872966 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80619220 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80418863 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78942741 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77722413 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 0.75631136 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69895584 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69058473 |
| 43 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66744922 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66734308 |
| 45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64312239 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61978279 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61320589 |
| 48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59460549 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58828332 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57601924 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56946508 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55763817 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.55094077 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55052770 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.52798217 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.52559728 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.51571429 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.48935018 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48370364 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48142002 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46699853 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46191671 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45551959 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44782056 |
| 65 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43929456 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42228514 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41289069 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.40538054 |
| 69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39473890 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39228640 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.37859459 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.37497009 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37083122 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34940418 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34498780 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.33851601 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32793142 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32379492 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.30923229 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29000018 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.28678211 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27878724 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.26777726 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26760875 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25936819 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25668088 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25399382 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25074826 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24768227 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24532856 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24429525 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23472477 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.23192448 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22200800 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.22195083 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21909918 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21539836 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21507497 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20515177 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20119449 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19085432 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18856315 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.18320115 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17480126 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.17466578 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16877461 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16584611 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16215105 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15831657 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15456868 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.14387266 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.14192359 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.11839042 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11676993 |
| 115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.11385774 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.09133181 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.08514654 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.08106463 |
| 119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06435243 |
| 120 | Morphine addiction_Homo sapiens_hsa05032 | 0.06228649 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.05541124 |

